ATH 33.3% 0.4¢ alterity therapeutics limited

Share price, page-8

  1. 1,640 Posts.
    lightbulb Created with Sketch. 143
    Share price is completely bonkers.. The market giving 0 speculative value for a drug going into clinical trial in 2 to 3 months.

    Is the market is anticipating that it won't get past safety tests? Or that Prana can't even organise a P1 trial to get off the ground?

    Strange. Not many shares on offer here at this level but why sell at cash value?
    Last edited by m123456: 23/03/18
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.